Inventiva’s Lanifibranor On NASH Path After Phase II Success In NAFLD Patients With Diabetes

But All Eyes On NASH

 
• By Ayisha Sharma
tree pruned into shape of liver
The NASH Market Could Br Worth $26bn In Future • Source: Shutterstock

More from Clinical Trials

More from R&D